Pricing

Log inSign up

Stoke Therapeutics

0 followers

‌

Stoke Therapeutics is pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression.

Industries

Biotechnology

Headquarters

Bedford, United States

Employees

51-200

Links

Org chart

Edward M. Kaye
CEO & Director

Edward M. Kaye

Collapse
Stephen J. Tulipano
CFO
Dawn Kalmar
Chief Communications Officer
Barry S. Ticho
Chief Medical Officer
Shamim Ruff
Chief Regulatory Officer
Huw M. Nash
Chief Operating & Business Officer
Jonathan Allan
General Counsel
Isabel Aznarez
Co-Founder & VP, Discovery Research
Meena
VP, Bioanalytical, DMPK & Biomarker Development
CB
Christy Chaves Blaney
Senior Director, Head Of Talent Acquisition
KP
Kimberly Parkerson
Senior Vice President, Head Of Neurology Clinical Development
Lorene Kush
Executive Assistant To Chief Executive Officer
Malini Viswanathan Ph.D
Vice President Portfolio and Alliance Management
PS
Parisa S.
Executive Director, Patient Advocacy, Policy, And Stakeholder Engagement
SY
Stephen Yu
VP Head of IT
Jason Hoitt
Chief Commercial Officer (cco)

Board & advisors

SH
Seth L. Harrison
Chairman
AK
Adrian Krainer
Co-Founder & Director
Jennifer Burstein
Director
Arthur Levin
Director
Garry E. Menzel
Director
Julie Anne Smith
Director
Arthur Tzianabos
Director

Teams

+27

Research and Development

30 members

+9

Clinical Operations

12 members

+6

Leadership Team

9 members

+2

Clinical Operations

5 members

+3

Operations and Compliance

6 members

+2

Research and Development

5 members

Offices

Similar companies

Kura Oncology

20 followers

Krystal Biotech

6 followers

REVOLUTION Medicines

5 followers

MindMed

5 followers

Immunovant

5 followers

Stemline Therapeutics

3 followers

Dyne Therapeutics

3 followers

Valo

3 followers

Rigel Pharmaceuticals

3 followers

Tasso

3 followers

Viridian Therapeutics

2 followers

Explore companies